glaxosmithkline investor relations

Data Provided by Refinitiv. Through our consumer insights and dedication to innovation, we continue to bring the most trusted lawn and garden products to consumers worldwide. Contact Investor Relations. The Investor Relations website contains information about Innoviva, Inc.'s business for stockholders, potential investors, and financial analysts. user . The investor pages that follow are your resource for financial information about Portman Ridge Financial. GreenSky ® and GreenSky Patient Solutions ® are loan program names for certain consumer credit plans extended by participating lenders to borrowers for the purchase of goods and/or services from participating merchants/providers. 2021-02-05 MMMM D, YYYY. Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs, Warning against fraudulent internet recruitment activities, Hal Barron’s presentation at the 39th annual JP Morgan Virtual Healthcare Conference. You must click the activation link in order to complete your subscription. 1:25 pm. Our market sites can be reached by visiting our market selector. Thank you for joining us for our Q3 2020 results which were issued earlier today. Investor Relations Corporate Profile . Choose your path. We published our Annual Report 2020 on 09 March 2021. (See Financial Times, Feb 16 2001, David Pilling.) GlaxoSmithKline plc GSK announced that it has started a late-stage study, SWIFT-2, which will evaluate its anti-IL-5 monoclonal antibody candidate, GSK3511294, in patients with … 121%. GSK Media Enquiries. Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs, Disclosure of payments made to HCPs in the US, Digital, data and analytics professionals, COVID-19 information for patients and consumers, Our commitment to diversity in clinical studies. The company is expected to report EPS of $0.69, down 28.87% from the prior-year quarter. Responsible business is how we do business. Investor Relations IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. RioTinto Facebook. Select a Child Category. Investors Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting ... Trade marks are owned by or licensed to the GSK group of companies. English English français INVESTORS. Code Of Practices & Procedures For Fair Disclosure Of Unpubished Price Sensitive Information . Relevant information for investments in Henkel's shares and bonds. GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products. 8:53 am. 3888792. category. 1:37 am. Our purpose is to help people to do more, feel better, live longer. 3888792. Find out if GSK (XNYS) is the best investment for you. We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. QQQ 320.58. 12:36 pm. Institutional investment questions 5 Crescent Drive Philadelphia PA 19112. Agnico Eagle’s mission is to build a high-quality, manageable business that generates superior long-term returns per share by: Increasing gold production in lower risk jurisdictions. DOW 32,825.95. Vice President Investor Relations. Minimizing share dilution. Further information relevant to the local environment is available from the company or via the Product Information. GSK earnings call for the period ending June 30, 2020. Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients. T: +44 20 7781 1517 M: +44 7825 195 178. Investor relations; Board and Committees. © 2001-2021 GSK group of companies. Investor Relations UK. Sarah Elton-Farr-- Head of Investor Relations. RioTInto on Instagram. Why Investors Should Keep an Eye on Vuzix Corp . Google alphabet Investor Relations Investor Presentation. © 2001-2021 GlaxoSmithKline plc. We announced our full year and fourth quarter results for the period ended 31 December 2020 on Wednesday 3 February 2021. Investor relations Investor Information Corporate governance report Corporate governance report Year selection filter for news years. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. GlaxoSmithKline PLC (NYSE:GSK) Q3 2020 Earnings Conference Call October 28, 2020 10:00 AM ET. GlaxoSmithKline plc. Registrar. UK. Sharing our research. Apple Investor Relations Investor Presentation. Q4 & FY 2020 results . Email. Investor Relations; This page shows the institutions and funds most likely to invest in GSK / GlaxoSmithKline plc, based on analysis of their current holdings. Latest Stock Picks Investing Basics Premium Services. Investor relations. We released our full year 2020 results on Wednesday 3 February 2021. GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS. Investor relations Analyst presentation Analyst presentation Presentation. Investors will be hoping for strength from GSK as it approaches its next earnings release. Stockline. GSK Policies; BRR Related Policies; Policies; Investor Information. GlaxoSmithKline plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq: CVAC) today announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19 with the potential for a multi-valent approach to address multiple emerging variants in one vaccine. Researching GlaxoSmithKline (LON:GSK) shares? GSK Investor Relations. Investor Relations Overview Innoviva, Inc. is a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited (“GSK”), including RELVAR®/BREO® ELLIPTA® (fluticasone furoate/ vilanterol, “FF/VI”), ANORO® ELLIPTA® (umeclidinium bromide/ vilanterol, “UMEC/VI”) and TRELEGY® ELLIPTA® (the combination FF/UMEC/VI). Clare Peever M: +44 (0)7788 967 877. GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business. Stock Advisor Flagship service. … You can sign up for additional alert options at any time. GSK earnings call for the period ending September 30, 2020. Providing meaningful dividends. Fax: fax +44 (0)20 8047 7807. Sally Ferguson has taken over as global head of IR at pharmaceutical company GlaxoSmithKline . GlaxoSmithKline plc GSK announced that it has started a late-stage study, SWIFT-2, which will evaluate its anti-IL-5 monoclonal antibody candidate, GSK3511294, in patients with … Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA Shareview Website . Investors Glanbia is a global nutrition group with a broad portfolio of nutrition solutions and market-leading brands. GSK earnings call for the period ending June 30, 2020. Capital Market Information. This is our global website, intended for visitors seeking information on GSK’s worldwide business. Investors can contact Investor can write to: Nodal Officer :Shanu Saksena. Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA You should have received our press release and you can view the presentation on GSK's website. All rights reserved. Third Quarter 2019-20 06 February 2020. Investors Our investor proposition. GSK Registrar Contact Registrar. Sarah Elton-Farr-- Head ofInvestor Relations. Company Participants. Natalie Worley. Registrar. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. We want to help change this, using our scientific expertise, our partnerships and our global reach. Growing operating and free cash flows. Business Responsibility Report-2019 10 May 2019. GLAXOSMITHKLINE . Explore the latest news, different ways to stay in touch and available useful resources, Keep up to date with our news and recent announcements. Loading.... Popular Post. Netflix Investor Relations Investor Presentation. We are a global company delivering billions of healthcare products a year. Information for Takeda's investors and potential investors including IR News, financial results, reports, presentations, news on events and an IR Calendar. Sharing our research We are committed to reporting the results of clinical research that evaluates product efficacy, irrespective of whether the outcomes are perceived to be positive or negative. Why Agnico Eagle? Start a 14-day free trial to Morningstar Premium to unlock our take on GSK. Google alphabet Investor Relations Investor Presentation. Shares of Glaxo … Tel:+1 215 751 4611 Email:GSK.Investor-Relations@gsk.com. LSE price updated every 15 minutes. When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again. Trade marks are owned by or licensed to the GSK group of companies. Code of Conduct_Directors and Senior Mgmnt. Download [929.52 KB] GlaxoSmithKline. We are committed to reporting the results of clinical research that evaluate our medicines and vaccines, irrespective of whether the outcomes are perceived to be positive or negative. Shares of Glaxo … Investor Relations Global Contacts GlaxoSmithKline PLC ADR GSK Morningstar Rating Rating as of Mar 16, 2021. Fax: fax +44 (0)20 8047 7807. GlaxoSmithKline PLC (NYSE:GSK) Q3 2020 Earnings Conference Call October 28, 2020 10:00 AM ET. After submitting your request, you will receive an activation email to the requested email address. GSK Investor Relations UK Contact Investor Relations UK. Q3 2020 RESULTS . GlaxoSmithKline's physical mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. GlaxoSmithKline plc GSK will report fourth-quarter 2020 results on Feb 3, before market open. Responsible business is how we do business. user. GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products. Menno Sanderse. 1:37 am. Sarah EltonFarr (Head of Investor Relations):-Good morning and good afternoon. GreenSky ® and GreenSky Patient Solutions ® are loan program names for certain consumer credit plans extended by participating lenders to borrowers for the purchase of goods and/or services from participating merchants/providers. Ferguson and Mawdsley will continue to work together in their new roles. We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. Investor relations Investor Information Quarterly results Quarterly results Year selection filter for news years. Investors and analysts. The information you are about to be referred to may not comply with the local regulatory requirements. Policy for Vigil Mechanism And Whistle Blower. category. Key information. Download [929.52 KB] GlaxoSmithKline. Corporate Governance Report Quarter III 2019-20 13 January 2020. Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline. Action happening today: GlaxoSmithKline Investor Relations Office, 499 Park Ave, Btn 58th and 59th St, 21st floor. S&P. Australia. Minimum 15 minutes delayed. Timezone BST, NYSE price updated every 20 minutes. GSK Investor Relations Investor Presentation . GSK Nigeria Investors Financial Calendar. View our share price, financial results, annual reports and keep up to date with Diageo latest news and upcoming events for investors. Registered in England and Wales No. We are a clinical stage biopharmaceutical company, developing our immunology and immuno-oncology portfolio of monoclonal antibodies. GlaxoSmithKline plc 980 Great West Road Brentford Middlesex TW8 9GS. Analyst Presentation Quarter 3 2019-2020 06 February 2020. Wednesday, 28 October 2020 . Investor Relations. Learn More. GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business. The subsequent websites and web pages are intended for non-UK audiences. Tel: pref +44 (0)20 8047 5000. 3 Airline Stocks That Are Taking Off. PRESS RELEASE PR Newswire . Products We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Review GSK (XNYS) dividend yield and history, to decide if GSK is the best investment for you. GSK Registrar Contact Registrar. Shareholder Contacts . Sign up to receive email notifications when we publish a stock exchange announcement. Amar Jambaa. GSK Investor Relations UK Contact Investor Relations UK. Registered in England and Wales No. Investor Relations Stock Information. Policy on Corporate Social Responsibility. GlaxoSmithKline is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. Millions of people live with unmet healthcare needs. Investors will be hoping for strength from GSK as it approaches its next earnings release. This is our global website, intended for visitors seeking information on GSK’s worldwide business. GSK Nigeria Investors Financial Calendar. Company Participants. In all of our interactions with HCPs we aim to be transparent about our work, operate with integrity, and always put the interests of patients first. Establishes a new focused global consumer healthcare business with the independence and sustainability to deliver significant value Equity split of 32% Pfizer and 68% GlaxoSmithKline Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands. GSK Investor Relations Investor Presentation . S&P 500 3,962.71. Our market sites can be reached by visiting our. Latest Stock Picks Investing Basics ... Head of Investor Relations, who will introduce today's session.
glaxosmithkline investor relations 2021